Analysis of How the Term “Shall” Is Understood and Applied to the EU-HTA Regulation
The European Health Technology Assessment (EU-HTA) Regulation extensively uses the word “shall”, and its use has caused confusion among audiences unfamiliar with legal terminology [...]
Authors
- Bruno Fallissard
- Samuel Aballéa (ORCID: https://orcid.org/0000-0002-6037-2039)
- Pascal Auquier (ORCID: https://orcid.org/0000-0003-3496-1996)
- Claude Dussart (ORCID: https://orcid.org/0000-0002-1091-9139)
- Laurent Boyer (ORCID: https://orcid.org/0000-0003-1229-6622)
- Mondher Toumi
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Inserm (FR)
- Aix-Marseille Université (FR)
- Université Paris-Saclay (FR)
- Hospices Civils de Lyon (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Shell (Netherlands) (NL)
Publication Details
- Journal
- Journal of Market Access & Health Policy
- Published
- 2026-07-27
- DOI
- https://doi.org/10.3390/jmahp14030042
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00